» Articles » PMID: 27519598

Value and Efficiency of Sentinel Lymph Node Diagnostics in Patients with Penile Carcinoma with Palpable Inguinal Lymph Nodes As a New Multimodal, Minimally Invasive Approach

Overview
Date 2016 Aug 14
PMID 27519598
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The international guidelines recommend sentinel lymph node biopsy (SLNB) for lymph node staging in penile cancer with non-palpable inguinal lymph nodes (LN) but it is not recommended with palpable inguinal LN. The aim of this study was to evaluate the reliability and morbidity of SLNB in combination with an ultrasound-guided resection of suspect inguinal LNs as a new multimodal, minimally invasive staging approach in these patients.

Methods: We performed SLNB in 26 penile cancer patients with 42 palpable inguinal LNs. Prior to the combined staging procedures the patients underwent an ultrasound examination of the groins as well as planar lymphatic drainage scintigraphy and SPECT/CT scans. During the surgical procedure, the radioactive-labelled sentinel lymph nodes and, in addition, sonographically suspect LNs, were resected under ultrasound guidance. Follow-up screening was done by ultrasound examination of the groins according to the guidelines of the European Association of Urology.

Results: Nineteen groins of 42 preoperatively palpable inguinal findings were histologically tumor-positive. SLNB alone showed lymphogenic metastases in 14 groins. Sonography revealed five further metastatic groins, which would not have been detected during SLNB due to a tumor-related blockage of lymphatic drainage or a so-called re-routing of the tracer. During follow-up, none of the 28 groins with tumor-negative LN status showed any LN recurrence in this combined investigation technique. The median follow-up period was 46 (24 to 92) months. Morbidity of this procedure was low at 4.76 % in relation to the number of groins resp. 7.69 % in relation to the number of patients.

Conclusions: The results show that this combined procedure is a reliable multimodal diagnostic approach for treatment of penile cancer patients with palpable inguinal LNs. It is associated with low morbidity rates. SLNB alone would lead to a significantly higher false-negative rate in these patients. The encouraging results of this work can extend the range of indications for nuclear medicine in the form of SLNB using radioactive tracers in this patient group.

Citing Articles

The Role of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Tuberous Vas Deferens Tuberculosis and Metastatic Inguinal Lymph Nodes.

Zhang W, Ni T, Tang W, Yang G Diagnostics (Basel). 2023; 13(10).

PMID: 37238246 PMC: 10217217. DOI: 10.3390/diagnostics13101762.


Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma.

Cao J, Yang C, Han W, Xie Y, Liu Z, Jiang S Front Oncol. 2021; 11:641869.

PMID: 34150614 PMC: 8207884. DOI: 10.3389/fonc.2021.641869.


[Penile cancer: diagnosis and staging].

Sievert K, Drager D, Kohn F, Milerski S, Protzel C, Hakenberg O Urologe A. 2018; 57(4):418-422.

PMID: 29523915 DOI: 10.1007/s00120-018-0602-x.

References
1.
van Poppel H, Watkin N, Osanto S, Moonen L, Horwich A, Kataja V . Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6:vi115-24. DOI: 10.1093/annonc/mdt286. View

2.
Kizu H, Takayama T, Fukuda M, Egawa M, Tsushima H, Yamada M . Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol. 2005; 33(2):78-82. View

3.
Heyns C, Theron P . Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes. BJU Int. 2008; 102(3):305-9. DOI: 10.1111/j.1464-410X.2008.07628.x. View

4.
Gopman J, Djajadiningrat R, Baumgarten A, Espiritu P, Horenblas S, Zhu Y . Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort. BJU Int. 2015; 116(2):196-201. DOI: 10.1111/bju.13009. View

5.
van der Ploeg I, Olmos R, Nieweg O, Rutgers E, Kroon B, Hoefnagel C . The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med. 2007; 48(11):1756-60. DOI: 10.2967/jnumed.107.043372. View